-
Product Insights
NewContinuous Positive Airway Pressure (CPAP) Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
CPAP Devices Pipeline Market Report Overview A continuous positive airway pressure machine (CPAP) is used for the treatment of sleep apnea and in intensive care units as a form of ventilation. CPAP devices provide gentle and unobstructed breathing by delivering a steady constant pressure of air through a hose that is connected to a nasal mask, nasal pillow, or a full-face mask. The CPAP devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their...
-
Sector Analysis
NewMobility Market Size, Trends, Drivers and Challenges, Vendor Landscape, Opportunities and Forecast to 2027
Mobility Market Report Overview The global mobility market size was pegged at more than $36 billion in 2022. The market is expected to grow at a CAGR of more than 15% during the forecast period (2022-2027). The significant rise in the adoption of mobile solutions in enterprises has led to a parallel rise in demand for enterprise mobility management (EMM) solutions, which enable IT administrators to simplify and secure enterprise mobility implementations in their organizations. Mobility Market Outlook, 2022-2027 ($...
-
Sector Analysis
Fuchs Endothelial Corneal Dystrophy (FECD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Fuchs Endothelial Corneal Dystrophy Marketed and Pipeline Drugs Report Overview Fuchs Endothelial Corneal Dystrophy (FECD) is a bilateral, slowly progressive, often asymmetric corneal disease. FECD is a sporadic or autosomal dominant dystrophy involving the endothelial layer of the cornea. Key Mechanisms of Action (Pipeline) ·      Enzyme Inhibitor ·      Receptor Agonist ·      Protein and Peptide Inhibitor ·      Transporter Inhibitor Key Molecule Types (Pipeline) ·      Small Molecule ·      Biologic Key Routes of Administration (Pipeline) ·      Topical ·      Oral ·      Injection Top Sponsors...
-
Sector Analysis
Norway Statutory and Private Employee Benefits, 2024 Update
Norway Statutory and Private Employee Benefits Overview The Norwegian employee benefits market is predominantly controlled by the public social security system. However, the growth of labor-intensive industries has fuelled the growth of the country’s private benefits market over the last decade. In Norway, general social insurance schemes are provided to citizens through the public social security system, which is overseen by the Norwegian Labor and Welfare Administration (Arbeids- og velferdsetaten; NAV). This system is important to the welfare system of...
-
Sector Analysis
NewFriedreich Ataxia (FRDA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Friedreich Ataxia (FRDA) Marketed and Pipeline Drugs Report Overview Friedreich's Ataxia (FRDA) is a rare, genetic disorder. It is progressive and typically manifests between the ages of 10 and 15. The disorder is characterized by a gradual decline in coordination, muscle strength, and endurance. Individuals with FRDA often become reliant on wheelchairs as the condition advances. The Friedreich Ataxia (FRDA) marketed and pipeline drugs market research report includes an assessment of the disease epidemiology, leading marketed products with sales forecast,...
-
Sector Analysis
NewArgentina Statutory and Private Employee Benefits, 2024 Update
Argentina Statutory and Private Employee Benefits Overview The Argentina social security system is comprehensive covering a wide variety of benefits such as retirement, death in service, long-term disability, short-term sickness, medical, workers’ compensation insurance, and maternity and paternity benefits. Furthermore, in Argentina, employers offer additional benefits to their employees through a defined contribution pension system, group health insurance plans, group life insurance plans, and a group personal accident insurance plan. The defined contribution pension plans are not too prevalent in...
-
Sector Analysis
NewCzech Republic Statutory and Private Employee Benefits, 2024 Update
Czech Republic Statutory and Private Employee Benefits Report Overview The Czech Republic has a well-developed social security system. Employers, employees, and self-employed people contribute to the social security schemes. The country’s social security system is built on three pillars: compulsory social insurance, state social support system, and social assistance. Compulsory social insurance covers pension insurance, health insurance, and the national employment policy system. The non-contributory state social support system supports families with dependent children. The final pillar, tax-financed social assistance,...
-
Sector Analysis
NewPost-Operative Pain (POP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Post-Operative Pain (POP) Marketed and Pipeline Drugs Report Overview Post-operative pain (POP) is considered a form of acute pain due to surgical trauma with an inflammatory reaction and initiation of an afferent neuronal barrage. There could also be some generalized body pain before the operation with aggravation after the operation. This type of operation often needs complete or partial anesthesia. Disturbances in the channels and collaterals or the internal organs may be the cause. Key Mechanisms of Action (Marketed) ·      ...
-
Sector Analysis
Polycystic Ovarian Syndrome (PCOS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Polycystic Ovarian Syndrome (PCOS) Marketed and Pipeline Drugs Report Overview Polycystic Ovarian Syndrome (PCOS) is a complex condition characterized by elevated androgen levels, menstrual irregularities, and/or small cysts on one or both ovaries. It stands as the most prevalent hormonal disorder affecting females of reproductive age. Genetic and environmental factors are responsible for the etiology of this condition. Unhealthy lifestyle choices, dietary habits, or exposure to infectious agents tend to increase the risk of developing PCOS. Key Mechanisms of Action...
-
Product Insights
Likelihood of Approval Analysis for Chemotherapy Induced Nausea and Vomiting
Overview How likely is it that the drugs in Chemotherapy Induced Nausea and Vomiting will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Chemotherapy Induced Nausea and Vomiting Overview Chemotherapy-induced nausea and...